Skip to main content

Role of androgen receptor in prostatic neoplasia versus hyperplasia.

Journal articles  - Journal Article
Husain, I; Shukla, S; Soni, P; Husain, N
Published in: J Cancer Res Ther
2016

INTRODUCTION: Androgens play a fundamental role in the growth, differentiation, and maintenance of prostate tissue. The objective of the study was to evaluate and compare the androgen receptor (AR) expression in benign prostatic hyperplasia (BPH), prostatic intraepithelial neoplasia (PIN), and prostatic adenocarcinoma. A relationship between the Gleason score and AR expression was also determined in cases of prostatic adenocarcinoma. MATERIALS AND METHODS: A total of 25 cases were collected which included 10 cases of prostatic adenocarcinoma, 10 cases of BPH, and five cases of PIN. Histopathological evaluation was done to determine the type of lesion including Gleason scoring. Immunohistochemistry (IHC) was performed for AR using monoclonal anti-AR antibody. RESULTS: Specific AR immunostaining was present in all 25 cases in varying intensity. The staining was more intense in cases of adenocarcinoma and PIN as compared BPH. There was no significant statistical difference in the intensity of staining of AR. The Gleason score was inversely related to the intensity of AR staining in adenocarcinoma. There was no significant statistical association between the AR expression and tumor, necrosis, metastasis (TNM) stage. DISCUSSION: AR nuclear expression is present in benign and malignant prostatic epithelium. In this study, cases of prostate cancer demonstrated a higher staining intensity for AR when compared with BPH. The intensity of AR staining in prostate cancer significantly reduces as the Gleason grade of the tumor increases. The staining intensity for AR was heterogeneous specifically in cases of prostate cancer. Our results indicate that AR maybe considered as a prognostic marker in prostate cancer.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Cancer Res Ther

DOI

EISSN

1998-4138

Publication Date

2016

Volume

12

Issue

1

Start / End Page

112 / 116

Location

India

Related Subject Headings

  • Receptors, Androgen
  • Prostatic Neoplasms
  • Prostatic Intraepithelial Neoplasia
  • Oncology & Carcinogenesis
  • Neoplasms
  • Neoplasm Grading
  • Middle Aged
  • Male
  • Hyperplasia
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Husain, I., Shukla, S., Soni, P., & Husain, N. (2016). Role of androgen receptor in prostatic neoplasia versus hyperplasia. J Cancer Res Ther, 12(1), 112–116. https://doi.org/10.4103/0973-1482.151429
Husain, Irma, Saumya Shukla, Priyanka Soni, and Nuzhat Husain. “Role of androgen receptor in prostatic neoplasia versus hyperplasia.J Cancer Res Ther 12, no. 1 (2016): 112–16. https://doi.org/10.4103/0973-1482.151429.
Husain I, Shukla S, Soni P, Husain N. Role of androgen receptor in prostatic neoplasia versus hyperplasia. J Cancer Res Ther. 2016;12(1):112–6.
Husain, Irma, et al. “Role of androgen receptor in prostatic neoplasia versus hyperplasia.J Cancer Res Ther, vol. 12, no. 1, 2016, pp. 112–16. Pubmed, doi:10.4103/0973-1482.151429.
Husain I, Shukla S, Soni P, Husain N. Role of androgen receptor in prostatic neoplasia versus hyperplasia. J Cancer Res Ther. 2016;12(1):112–116.

Published In

J Cancer Res Ther

DOI

EISSN

1998-4138

Publication Date

2016

Volume

12

Issue

1

Start / End Page

112 / 116

Location

India

Related Subject Headings

  • Receptors, Androgen
  • Prostatic Neoplasms
  • Prostatic Intraepithelial Neoplasia
  • Oncology & Carcinogenesis
  • Neoplasms
  • Neoplasm Grading
  • Middle Aged
  • Male
  • Hyperplasia
  • Humans